World Of Taxonomy
50474-750Level 3

Cimzia (certolizumab pegol)

**Product type:** Human Prescription Drug

**Active ingredient:** CERTOLIZUMAB PEGOL

**Strength:** 200 mg/mL

**Dosage form:** Injection, Solution

**Route:** Subcutaneous

**Labeler:** UCB, Inc.

**Marketing category:** BLA (BLA125160)

**Pharmacologic class:** Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]

GET/api/v1/systems/ndc_fda/nodes/50474-750
Official DownloadPublic Domain (US Government)Source

Hierarchy Explorer

Loading...

Cross-system equivalences0

No cross-system equivalences mapped for this node.